Beech Tree Labs, Inc.   Report issue

For profit Phase 2
Founded: Providence RI United States (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2011
NCT01308424
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Beech Tree Labs, Inc. | President, Beech Tree Labs, Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

Thimerosal (3 trials)

uish001 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Enuresis (Phase 2)

Herpes Labialis (Phase 2)

Herpes Simplex (Phase 2)

Herpesviridae Infections (Phase 2)

Infections (Phase 2)

Stomatitis, Herpetic (Phase 2)

Urinary Incontinence (Phase 2)

Virus Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 2